AU2001273231A1 - Method for formulating healthcare products with enhanced stability - Google Patents

Method for formulating healthcare products with enhanced stability

Info

Publication number
AU2001273231A1
AU2001273231A1 AU2001273231A AU7323101A AU2001273231A1 AU 2001273231 A1 AU2001273231 A1 AU 2001273231A1 AU 2001273231 A AU2001273231 A AU 2001273231A AU 7323101 A AU7323101 A AU 7323101A AU 2001273231 A1 AU2001273231 A1 AU 2001273231A1
Authority
AU
Australia
Prior art keywords
active ingredient
excipients
polymers
substrate
formulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273231A
Other languages
English (en)
Inventor
Suggy S. Chrai
Troy M. Harmon
Ashok Katdare
Ramaswamy Murari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Delsys Pharmaceutical Corp
Original Assignee
Delsys Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delsys Pharmaceutical Corp filed Critical Delsys Pharmaceutical Corp
Publication of AU2001273231A1 publication Critical patent/AU2001273231A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001273231A 2000-07-06 2001-07-06 Method for formulating healthcare products with enhanced stability Abandoned AU2001273231A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21620500P 2000-07-06 2000-07-06
US60216205 2000-07-06
PCT/US2001/021418 WO2002003965A1 (fr) 2000-07-06 2001-07-06 Procede de formulation de produits d'hygiene personnelle a stabilite amelioree

Publications (1)

Publication Number Publication Date
AU2001273231A1 true AU2001273231A1 (en) 2002-01-21

Family

ID=22806160

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001273231A Abandoned AU2001273231A1 (en) 2000-07-06 2001-07-06 Method for formulating healthcare products with enhanced stability

Country Status (10)

Country Link
US (1) US20050013924A1 (fr)
EP (1) EP1296653A4 (fr)
JP (1) JP2004502724A (fr)
KR (1) KR20030023692A (fr)
CN (1) CN1441669A (fr)
AU (1) AU2001273231A1 (fr)
CA (1) CA2415082A1 (fr)
HU (1) HUP0301415A2 (fr)
IL (1) IL153798A0 (fr)
WO (1) WO2002003965A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005015128B4 (de) * 2005-03-31 2008-12-11 Bayer Schering Pharma Aktiengesellschaft Wafer enthaltend Steroidhormone
US7794774B2 (en) * 2005-11-07 2010-09-14 The Quaker Oats Company Long shelf-life high moisture content cereal products
US20090157185A1 (en) * 2007-12-18 2009-06-18 Chong Chol Kim Prosthetic Monolithic Spinal Discs and Method of Customizing and Constructing Discs
AU2016321659A1 (en) * 2015-09-14 2018-05-10 Merck Patent Gmbh Formulation having controlled, delayed active-ingredient release
MX2022000309A (es) 2019-07-09 2022-03-17 Oerlikon Metco Us Inc Aleaciones a base de hierro dise?adas para resistencia al desgaste y la corrosion.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031200A (en) * 1975-12-15 1977-06-21 Hoffmann-La Roche Inc. Manufacture of pharmaceutical unit dosage forms
GB2253164B (en) * 1991-02-22 1994-10-05 Hoechst Uk Ltd Improvements in or relating to electrostatic coating of substrates of medicinal products
US5714007A (en) * 1995-06-06 1998-02-03 David Sarnoff Research Center, Inc. Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
US5846595A (en) * 1996-04-09 1998-12-08 Sarnoff Corporation Method of making pharmaceutical using electrostatic chuck
NZ508402A (en) * 1998-06-10 2003-08-29 Delsys Pharmaceutical Corp Dry powder deposition apparatus for electrostatic deposition of a pharmaceutical powder

Also Published As

Publication number Publication date
IL153798A0 (en) 2003-07-31
CA2415082A1 (fr) 2002-01-17
HUP0301415A2 (hu) 2003-09-29
CN1441669A (zh) 2003-09-10
KR20030023692A (ko) 2003-03-19
WO2002003965A1 (fr) 2002-01-17
US20050013924A1 (en) 2005-01-20
EP1296653A4 (fr) 2005-09-21
JP2004502724A (ja) 2004-01-29
EP1296653A1 (fr) 2003-04-02

Similar Documents

Publication Publication Date Title
FI90393B (fi) Menetelmä oraalisen, farmaseuttisen valmisteen valmistamiseksi, joka on pysyvä värin muuttumista vastaan
SU1706373A3 (ru) Способ получени средства с регулируемым высвобождением активного соединени
US20020077364A1 (en) Thyroid hormone formulations
TWI474820B (zh) 安定之提古黴素類（ｔｉａｃｕｍｉｃｉｎｓ）之組成物
EP1720527A2 (fr) Composition pharmaceutique stable comprenant un medicament labile en milieu acide
JP2002528485A (ja) 多粒子改質放出組成物
WO2007097770A1 (fr) Comprimés de succinate de métoprolol er et méthodes pour leur préparation
CN101686947A (zh) 度洛西汀制剂
US20050013924A1 (en) Method for formulating healthcare products with enhanced stability
CN102631327B (zh) 一种奥美拉唑肠溶微丸及其制备方法
CN1321642C (zh) 泮托拉唑钠肠溶微丸
EP4205729A1 (fr) Pellet gastro-résistant, son procédé de préparation et préparation le comprenant
CN104274387A (zh) 美托洛尔缓释组合物
EP0908177B1 (fr) Procédé pour former des compositions pharmaceutiques de bromazépam sous forme de granules ou pilules sphériques à action controlée et soutenue et compositions pharmaceutiques obtenues par ce procédé
WO2003077829A2 (fr) Procede de preparation de composition pharmaceutique
WO2023147443A2 (fr) Nouvelles compositions
EA009957B1 (ru) Фармацевтическая композиция с замедленным высвобождением, включающая венлафаксин
IL139894A (en) Stable benzimidazole composition and a method for producing it
NZ510231A (en) Omeprazole formulation comprising an alkaline core and an enteric coating